Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuler Spigener

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Pharmaceutical Compounding|December 6, 2014
Compounded pain formulations: what is the evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|April 11, 2024
Compounded Pain Formulations: What is the Evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|December 22, 2015
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment TimeAllie Heustess, Shuler Spigener, Sarah Sweitzer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutical Compounding|December 6, 2014
Compounded pain formulations: what is the evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|April 11, 2024
Compounded Pain Formulations: What is the Evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|December 22, 2015
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment TimeAllie Heustess, Shuler Spigener, Sarah Sweitzer, et al.
Pageof 1